Vital Bio

VitalBio is building a new era of diagnostics aimed at making healthcare radically accessible, developing tools that reimagine how biomarkers are measured in order to prevent disease, reduce inequality in wellbeing, and give patients and providers better real-time information. The company's initial products target care for its most vulnerable patient populations before expanding into broader preventative health. VitalBio is backed by investors including Sam Altman, Marc Benioff, Northpond Ventures, and Labcorp.